Related Experiment Videos
Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death
James E Bailey1, Jim Y Wan, Jun Tang
1Division of General Internal Medicine, Department of Medicine, University of Tennessee Health Science Center, 956 Court Avenue, Coleman D222, Memphis, TN 38163, USA. jeb@uthsc.edu
Insights
Improving adherence to antihypertensive medications and increasing ambulatory visits significantly reduce stroke and death risks in hypertensive patients. Even a small increase in medication adherence lowers the hazard of stroke and death.
Area of Science:
- Cardiovascular Medicine
- Public Health
- Pharmacoeconomics
Background:
- Hypertension management is critical for preventing cardiovascular events.
- Understanding factors influencing outcomes in community-dwelling hypertensive patients is essential.
Purpose of the Study:
- To investigate the association between antihypertensive medication refill adherence, ambulatory visits, and stroke/death in hypertensive patients.
- To evaluate the impact of different antihypertensive medication classes on patient outcomes.
Main Methods:
- Retrospective cohort study of 49,479 hypertensive patients in Tennessee's Medicaid program (1994-2000).
- Analysis of administrative and pharmacy refill data over 3-7 years.
- Cox proportional hazards modeling to assess associations with stroke and death.
Main Results:
- Increased medication adherence was linked to reduced hazards of stroke and death.
- Higher baseline adherence correlated with a 9% decrease in stroke hazard per 15% adherence increase.
- Ambulatory visits were associated with decreased mortality; thiazide diuretics specifically reduced stroke risk.
Conclusions:
- Ambulatory visits and specific antihypertensive medication exposures are associated with reduced mortality.
- Improving medication adherence by one pill weekly for a daily regimen reduces stroke hazard by 8-9% and death hazard by 7%.
Background:
This study seeks to determine whether antihypertensive medication refill adherence, ambulatory visits, and type of antihypertensive medication exposures are associated with decreased stroke and death for community-dwelling hypertensive patients.
Methods:
This retrospective cohort study included all chronic medication-treated hypertensives enrolled in Tennessee's Medicaid program (TennCare) for 3-7 years during the period 1994-2000 (n = 49,479). Health care utilization patterns were evaluated using administrative data linked to vital records during a 2-year run-in period and 1- to 5-year follow-up period. Antihypertensive medication refill adherence was calculated using pharmacy records.
Results:
Associations with stroke and death were assessed using Cox proportional hazards modeling. Stroke occurred in 619 patients (1.25%) and death in 2,051 (4.15%). Baseline antihypertensive medication refill adherence was associated with decreased multivariate hazards of stroke [hazard ratio (HR) 0.91; 95% confidence interval (CI), 0.86-0.97 for 15% increase in adherence]. Adherence in the follow-up period was associated with decreased hazards of stroke (HR 0.92; CI 0.87-0.96) and death (HR 0.93; CI 0.90-0.96). Baseline ambulatory visits were associated with decreased death (HR 0.99; CI 0.98-1.00). Four major classes of antihypertensive agents were associated with mortality reduction. Only thiazide-type diuretic use was associated with decreased stroke (HR 0.89; CI 0.85-0.93).
Conclusions:
Ambulatory visits and antihypertensive medication exposures are associated with reduced mortality. Increasing adherence by one pill per week for a once-a-day regimen reduces the hazard of stroke by 8-9% and death by 7%.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Hypertension III: Clinical Manifestations and Diagnostic Studies
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care
Errors occurring during blood pressure monitoring
Several factors...